| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-09 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |